NovoCure's (NVCR) Outperform Rating Reiterated at Leerink Partnrs

Leerink Partnrs reissued their outperform rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on Friday, PriceTargets.com reports. NVCR has been the subject of a number of other research reports. SVB Securities initiated coverage on shares of NovoCure in a research report on Friday. They issued an outperform rating and […]

Related Keywords

United States ,Japan ,China ,Cambridge ,Cambridgeshire ,United Kingdom ,Leerink Partnrs ,Optune Lua ,Piper Sandler ,Sectoral Asset Management Inc ,Baird Financial Group Inc ,Daiwa Securities Group Inc ,Wells Fargo Company ,Novocure Company Profile ,Cambridge Investment Research Advisors Inc ,Free Report ,Wells Fargo ,Moderate Buy ,Get Free Report ,Asset Management ,Investment Research Advisors ,Securities Group ,Baird Financial Group ,Financial Group ,Cure Limited ,Middle East ,Novocure Daily ,Novocure ,Nasdaq Nvcr ,Nvcr ,Medical ,Reiterated Rating ,